Results 271 to 280 of about 887,968 (372)

Rationale and design of the FAIR‐HF2‐DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
Study overview describing the intravenous iron supplementation protocol during the repletion and the maintenance phases, duration of follow‐up, and the three co‐primary endpoints. CV, cardiovascular, HF, heart failure; TSAT, transferrin saturation.
Stefan D. Anker   +9 more
wiley   +1 more source

What is the influence of exacerbations on pulmonary function in pediatric and adolescent patients with severe asthma despite controller therapies? [PDF]

open access: yesClin Transl Allergy
Brandão AZP   +7 more
europepmc   +1 more source

Alcohol consumption and incident heart failure in men and women

open access: yesEuropean Journal of Heart Failure, EarlyView.
Alcohol consumption and incident heart failure (HF) in men and women. Abstract Aims Regular heavy alcohol consumption may lead to the development of alcohol‐related cardiomyopathy and symptomatic heart failure (HF) later in life. However, the dose–response relationship between alcohol consumption and risk for incident HF, and whether these associations
Hailun Qin   +3 more
wiley   +1 more source

Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study

open access: yesEuropean Journal of Heart Failure, EarlyView.
Time of diagnosis of comorbidities in relation to heart failure. COPD, chronic obstructive pulmonary disease; MI, myocardial infarction. Abstract Aims Heart failure (HF) is frequently associated with multiple comorbidities. We aimed to define their trajectory of accrual to identify opportunities for disease prevention. Methods and results We identified
Hugo MacGowan   +12 more
wiley   +1 more source

Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status. BMI, body mass index; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.
Jawad H. Butt   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy